Table 1. | PICO guidelines |
Population (P) | Edentulous or partially edentulous patients with autoimmune diseases |
Intervention (I) | Dental implant therapy |
Comparison (C) | None |
Outcomes (O) |
Primary: implant survival rate Secondary: suprastructure survival rate and success rate including biological complications (e.g., crestal bone loss, peri-implantitis, and peri-implant mucositis), technical complications and patient-reported outcomes |
Focused question | What is the impact of autoimmune diseases and their medical treatment on dental implant survival and success? |